|
|
XTL Biopharmaceuticals Ltd
TLV •
Healthcare •
Biotechnology •
Quote as of 06/05/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTLV
Market Capitalization16.09 mln
Float275 mln
Earnings Date06/03/2026
Key Fundamentals
EPS-0.03
ROE-248
RPS0.00
ROIC-146
ROA-162
EBITDA, mln-18.58
EV / EBITDA-0.89
EV / EBIT-0.87
Revenue, mln2.81
EV / Revenue5.91
Financial Strength
Altman Z-Score-25.41
Piotroski F-Score
3
/ 9
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-5.56% |
28
/ 100
 |
| 1 Month |
-39.29% |
1
/ 100
 |
| 2 Months |
-37.04% |
2
/ 100
|
| 6 Months |
-39.29% |
5
/ 100
 |
| 1 Year |
-62.22% |
2
/ 100
|
|
| |
